case_images: PMC3665239_01
case_images: Hemoglobin and creatine response with rituximab intervention.
case_images: CRIM.HEMATOLOGY2013-130978.001.jpg
case_images: PMC3665239_01_CRIM.HEMATOLOGY2013-130978.001.jpg
case_images: fig1
case_images: She remains in remission from the microangiopathic hemolytic anemia and thrombocytopenia now 11 months after her initial presentation, though her renal function has still not returned to her baseline (Figures 1 and 2, Table 1).
case_images: Platelet count, LDH, and haptoglobin response with rituximab intervention.
case_images: CRIM.HEMATOLOGY2013-130978.002.jpg
case_images: PMC3665239_01_CRIM.HEMATOLOGY2013-130978.002.jpg
case_images: fig2
case_images: She remains in remission from the microangiopathic hemolytic anemia and thrombocytopenia now 11 months after her initial presentation, though her renal function has still not returned to her baseline (Figures 1 and 2, Table 1).